ストックスクリーナーアプリを入手
2.07
5.48%
-0.12
アフターアワーズ：
2.04
-0.03
-1.45%
Marker Therapeutics Inc (MRKR) 最新ニュース
How strong is Marker Therapeutics Inc. stock balance sheetWeekly Risk Report & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Can Marker Therapeutics Inc. stock sustain market leadership2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - ulpravda.ru
Why Marker Therapeutics Inc. (GX1) stock could rally stronglyDay Trade & Verified High Yield Trade Plans - ulpravda.ru
Will Marker Therapeutics Inc. stock benefit from commodity pricesTrade Volume Report & Free Community Consensus Stock Picks - ulpravda.ru
Why Marker Therapeutics Inc. stock remains on buy listsJuly 2025 Earnings & Fast Exit and Entry Trade Guides - ulpravda.ru
How sustainable is Marker Therapeutics Inc. stock dividend payoutPortfolio Value Summary & Stepwise Trade Signal Implementation - ulpravda.ru
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance
Marker Therapeutics, Inc. (MRKR) now trades above golden cross: Time to buy? - MSN
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance
Marker Therapeutics stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com UK
Is Marker Therapeutics Inc GX1 a good long term investmentMarket Sentiment Shifts & Buy Sell Signal Notifications - earlytimes.in
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Brookline Capital raises Marker Therapeutics stock price target to $5.60 By Investing.com - Investing.com Canada
Marker Therapeutics Reports Positive Phase 1/2 Clinical Study Results for Multi-Antigen Targeted T Cells in Pancreatic Cancer Patients - Quiver Quantitative
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer - The Manila Times
Wall Street Zen Upgrades Marker Therapeutics (NASDAQ:MRKR) to Hold - Defense World
MRKR stock touches 52-week low at $1.8 amid market challenges - MSN
Why Marker Therapeutics Inc stock remains undervaluedMarket Trend Review & Verified Stock Trade Ideas - moha.gov.vn
Trade Recap: How Marker Therapeutics Inc GX1 stock reacts to monetary easing2025 Major Catalysts & Smart Investment Allocation Tips - moha.gov.vn
Nasdaq Moves: Is Mineralys Therapeutics Inc stock a safe investment in uncertain marketsJuly 2025 Outlook & Real-Time Volume Spike Alerts - moha.gov.vn
MRKR stock touches 52-week low at $2.4 amid challenging year - MSN
Technical Analysis: Amber Enterprises India Limited (AMBER)Stock Correlation Metrics & Superior Return Stocks - bollywoodhelpline.com
Moving Average Crossover Confirms Uptrend in Dharani Sugars and Chemicals LimitedEnergy Sector Updates & Interactive Charts for Smarter Trading - bollywoodhelpline.com
Fed Watch: Can Marker Therapeutics Inc stock deliver 10 annual returnsQuarterly Profit Report & Fast Gaining Stock Reports - moha.gov.vn
Can Prabhu Steel Industries Limited Bounce Back From Weekly LowFundamental Stock Analysis & Low Cost Trading Tips - bollywoodhelpline.com
Svam Software Limited Approaches Psychological Resistance LevelEconomic Impact on Stocks & Free Quantitative Trading Strategies - Bollywood Helpline
Sentiment Review: Will Marker Therapeutics Inc. stock benefit from green energy trendsPrice Action & Consistent Income Trade Ideas - moha.gov.vn
Can Marker Therapeutics Inc. stock withstand economic slowdown2025 Key Lessons & Capital Efficiency Focused Ideas - Улправда
What insider trading reveals about Marker Therapeutics Inc. stockRisk Management & Real-Time Stock Price Movement Reports - Улправда
Risk Report: Can Marker Therapeutics Inc. stock withstand economic slowdown2025 Support & Resistance & Precise Swing Trade Alerts - Улправда
Will Marker Therapeutics Inc. stock benefit from green energy trends2025 Market Outlook & AI Driven Stock Reports - Улправда
Risk Hedge: What insider trading reveals about Marker Therapeutics Inc. stockQuarterly Earnings Report & Proven Capital Preservation Tips - Улправда
Will Marker Therapeutics Inc. stock deliver shareholder valueJuly 2025 Weekly Recap & High Conviction Trade Alerts - DonanımHaber
Marker Therapeutics Earnings Notes - Trefis
Is Marker Therapeutics Inc. stock trading near support levelsJuly 2025 Levels & Fast Entry and Exit Trade Plans - Улправда
Retail Surge: Can Marker Therapeutics Inc. stock surprise with earnings upside2025 Volatility Report & High Accuracy Swing Trade Signals - ulpravda.ru
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers - RTTNews
How Marker Therapeutics Inc. (GX1) stock reacts to new regulationsJuly 2025 Earnings & Low Volatility Stock Recommendations - Улправда
Here's Why Marker Therapeutics (NASDAQ:MRKR) Must Use Its Cash Wisely - Yahoo Finance
US High Growth Tech Stocks To Watch December 2025 - simplywall.st
Marker Therapeutics, Inc. (NASDAQ:MRKR) Receives Consensus Rating of “Buy” from Analysts - Defense World
How strong is Marker Therapeutics Inc stock balance sheet2025 Top Decliners & Weekly High Return Opportunities - moha.gov.vn
Panic Selling: Is Marker Therapeutics Inc stock supported by strong cash flows2025 Pullback Review & Reliable Momentum Entry Alerts - moha.gov.vn
Published on: 2025-12-13 20:42:44 - moha.gov.vn
What drives Marker Therapeutics Inc GX1 stock priceDividend Stability Analysis & Consistent Triple Returns - earlytimes.in
FY2025 Earnings Forecast for MRKR Issued By HC Wainwright - Defense World
Marker Therapeutics (NASDAQ:MRKR) Coverage Initiated at HC Wainwright - Defense World
H.C. Wainwright reiterates Buy rating on Marker Therapeutics stock By Investing.com - Investing.com Canada
HC Wainwright & Co. Initiates Coverage of Marker Therapeutics (MRKR) with Buy Recommendation - Nasdaq
MRKR: HC Wainwright & Co. Initiates Coverage with a 'Buy' Rating - GuruFocus
Check Out Lam Research Corp (LRCX)’s Trade Data Rather Than the Analysts’ Views - setenews.com
Why Marker Therapeutics Inc. stock remains on watchlistsWeekly Trend Report & AI Forecasted Stock Moves - Newser
How analysts revise price targets for Marker Therapeutics Inc. (GX1) stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - Newser
Acute Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight - Business Upturn
Is Marker Therapeutics Inc. stock supported by innovation pipelineMarket Performance Recap & Advanced Technical Signal Analysis - Newser
Is Marker Therapeutics Inc. (GX1) stock good for long term investingJuly 2025 PostEarnings & Safe Entry Trade Reports - Newser
Why ETFs are accumulating Marker Therapeutics Inc. (GX1) stockProduct Launch & Safe Entry Trade Signal Reports - Newser
Recovery Setup Building in AVI Polymers Limited Experts SayPrice-to-Earnings Ratio Insights & Capital Planning and Optimization - earlytimes.in
Marker Therapeutics (MRKR) Stock Analysis Report | Financials & Insights - Benzinga
Marker Therapeutics (NASDAQ:MRKR) Downgraded by Wall Street Zen to Sell - Defense World
0.80%
4.56%
大文字化:
|
ボリューム (24 時間):